Literature DB >> 27221574

Incidence and Risk Factors for Prolonged Hospitalization and Readmission after Transsphenoidal Pituitary Surgery.

Andrés M Bur1, Jason A Brant2, Jason G Newman2, Kyle M Hatten2, Steven B Cannady2, John P Fischer3, John Y K Lee4, Nithin D Adappa2.   

Abstract

OBJECTIVE: To evaluate the incidence and factors associated with 30-day readmission and to analyze risk factors for prolonged hospital length of stay following transsphenoidal pituitary surgery. STUDY
DESIGN: Retrospective longitudinal claims analysis.
SETTING: American College of Surgeons National Surgical Quality Improvement Program. SUBJECTS AND METHODS: The database of the American College of Surgeons National Surgical Quality Improvement Program was queried for patients who underwent transsphenoidal pituitary surgery (Current Procedural Terminology code 61548 or 62165) between 2005 and 2014. Patient demographic information, indications for surgery, and incidence of hospital readmission and length of stay were reviewed. Risk factors for readmission and prolonged length of stay, defined as >75th percentile for the cohort, were identified through logistic regression modeling.
RESULTS: A total of 1006 patients were included for analysis. Mean hospital length of stay after surgery was 4.1 ± 0.2 days. Predictors of prolonged length of stay were operative time (P < .001, odds ratio [OR] = 1.7, 95% confidence interval [95% CI] = 1.5-2.0), bleeding disorder (P = .049, OR = 3.1, 95% CI = 1.0-9.5), insulin-dependent diabetes (P = .007, OR = 2.4, 95% CI = 1.3-4.4), and reoperation (P < .001, OR = 10.3, 95% CI = 4.7-23.9). In a subset analysis of 529 patients who had surgery between 2012 and 2014, 7.2% (n = 38) required hospital readmission. History of congestive heart failure (CHF) was a predictor of hospital readmission (P = 0.03, OR = 12.7, 95% CI = 1.1-144.0).
CONCLUSION: This review of a large validated surgical database demonstrates that CHF is an independent predictor of hospital readmission after transsphenoidal surgery. Although CHF is a known risk factor for postoperative complications, it poses unique challenges to patients with potential postoperative pituitary dysfunction. © American Academy of Otolaryngology—Head and Neck Surgery Foundation 2016.

Entities:  

Keywords:  National Surgical Quality Improvement Program; length of stay; pituitary surgery; readmission; transsphenoidal

Mesh:

Year:  2016        PMID: 27221574     DOI: 10.1177/0194599816652379

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  5 in total

1.  Socioeconomic Factors Affecting Discharge Status of Patients with Uncomplicated Transsphenoidal Adenohypophysectomy.

Authors:  Chelsea S Hamill; Jennifer A Villwock; Kevin J Sykes; Roukoz B Chamoun; D David Beahm
Journal:  J Neurol Surg B Skull Base       Date:  2018-02-26

2.  Endoscopic versus nonendoscopic surgery for resection of pituitary adenomas: a national database study.

Authors:  Khodayar Goshtasbi; Brandon M Lehrich; Mehdi Abouzari; Arash Abiri; Jack Birkenbeuel; Ming-Ying Lan; Wei-Hsin Wang; Gilbert Cadena; Frank P K Hsu; Edward C Kuan
Journal:  J Neurosurg       Date:  2020-03-13       Impact factor: 5.115

3.  Diabetes insipidus and syndrome of inappropriate antidiuresis (SIADH) after pituitary surgery: incidence and risk factors.

Authors:  Elena L Sorba; Victor E Staartjes; Stefanos Voglis; Lazar Tosic; Giovanna Brandi; Oliver Tschopp; Carlo Serra; Luca Regli
Journal:  Neurosurg Rev       Date:  2020-06-24       Impact factor: 3.042

4.  30-Day Readmissions and Coordination of Care Following Endoscopic Transsphenoidal Pituitary Surgery: Experience with 409 Patients.

Authors:  Michael K Ghiam; Darius E Chyou; Cortney L Dable; Andrew P Katz; Daniel G Eichberg; Hang Zhang; Alejandro R Ayala; Atil Y Kargi; Ricardo J Komotar; Zoukaa Sargi
Journal:  J Neurol Surg B Skull Base       Date:  2021-05-25

5.  Incidence and risk factors of delayed postoperative hyponatremia after endoscopic endonasal surgery for Rathke's cleft cyst: A single-center study.

Authors:  Ao Qian; Jing Zhou; Jiaojiao Yu; Gang Huo; Xiaoshu Wang
Journal:  Front Surg       Date:  2022-07-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.